Showing 2301-2310 of 9397 results for "".
Aesthetics Update: A Q&A With Modern Aesthetics® editors Saami Khalifian, MD, and Kay Durairaj, MD, FACS
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetics-update-a-qa-with-modern-aesthetics-editors-saami-khalifian-md-and-kay-durairaj-md-facs/29203/The world of aesthetic medicine is rapidly evolving, from next-generation polynucleotides and biostimulators to shifts in patient demands and perceptions of beauty. To discuss the latest trends in aesthetics, Practical Dermatology® turned to its sister publication, Modern Aesthetics®, and new ChiefFresh Content Can Keep Your Dermatology Website in Top Rankings
https://practicaldermatology.com/topics/practice-management/fresh-content-can-keep-your-dermatology-website-in-top-rankings/22909/It is critically important to use multi-pronged approaches that lead your website onto the top of search engine page rankings. Great content is key.How Ichthyosis Can Affect Mental Health—And How We Can Address It
https://practicaldermatology.com/programs/practical-dermatology/how-ichthyosis-can-affect-mental-health-and-how-we-can-address-it/24029/As a rare condition, ichthyosis can bring additional burdens upon patients and caregivers alike.How Do You Compare? Financial Benchmarking Survey Measures Aesthetic Market
https://practicaldermatology.com/topics/practice-management/how-do-you-compare-financial-benchmarking-survey-measures-aesthetic-market/23002/Results of an annual benchmarking survey among medical aesthetic, dermatology, and medispa practices across the US.Rosacea Unveiled: A YoungMD Connect Open Discussion with Dr. Corey Hartman
https://practicaldermatology.com/youngmd-connect/wrap-ups/rosacea-unveiled-a-youngmd-connect-open-discussion-with-dr-corey-hartman/27168/In his YoungMD Connect virtual session on the topic of rosacea, Dr. Corey Hartman shared extensive experience with the eager viewing audience. Topics discussed included treating patients with rosacea, including those with skin of color, as well as clinical pearls on diagnosing and managing this commOptimizing Skin Exams with a Next-Gen Wireless Handheld Dermoscopy Solution
https://practicaldermatology.com/topics/practice-management/optimizing-skin-exams-with-a-next-gen-wireless-handheld-dermoscopy-solution/23571/The Barco Demetra Dermoscopy solution combines features of analog and digital imaging to support clinical decision-making for a range of skin presentations.Curing the Blues: Resolution of the Tyndall Effect Through Removal of a Misplaced NASHA Filler with Hyaluronidase
https://practicaldermatology.com/topics/general-topics/PD0509_11-php/22833/Implantation of NASHA fillers too superficially can produce the Tyndall effect. Besides aesthetic elegance, longevity after injection and an excellent safety record, a significant advantage of NASHA fillers is that they are reversible when misplaced.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/videos/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/across-the-lifespan-understanding-the-cutaneous-impact-of-hormonal-fluctuations-on-womens-skincare/24027/Drs. Hope Mitchell, Mary Lupo, and Elizabeth Houshmand, talk with Practical Dermatology® about the unique challenges of tailoring women’s skincare to their specific needs.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical man